Literature DB >> 26250578

TIGIT-positive circulating follicular helper T cells display robust B-cell help functions: potential role in sickle cell alloimmunization.

Emmanuelle Godefroy1, Hui Zhong1, Petra Pham2, David Friedman3, Karina Yazdanbakhsh4.   

Abstract

T follicular helper cells are the main CD4(+) T cells specialized in supporting B-cell responses, but their role in driving transfusion-associated alloimmunization is not fully characterized. Reports of T follicular helper subsets displaying various markers and functional activities underscore the need for better characterization/identification of markers with defined functions. Here we show that a previously unidentified subset of human circulating T follicular helper cells expressing TIGIT, the T-cell immunoreceptor with Ig and immunoreceptor tyrosine-based inhibitory domains, exhibit strong B-cell help functions. Compared to the subset lacking the receptor, T follicular helper cells expressing this receptor up-regulated co-stimulatory molecules and produced higher levels of interleukins (IL-21 and IL-4) critical for promoting B-cell activation/differentiation. Furthermore, this subset was more efficient at inducing the differentiation of B cells into plasmablasts and promoting immunoglobulin G production. Blocking antibodies abrogated the B-cell help properties of receptor-expressing T follicular helper cells, consistent with the key role of this molecule in T follicular helper-associated responses. Importantly, in chronically transfused patients with sickle cell anemia, we identified functional differences of this subset between alloimmunized and non-alloimmunized patients. Altogether, these studies suggest that expression of the T-cell immunoreceptor with Ig and immunoreceptor tyro-sine-based inhibitory domains not only represents a novel circulating T follicular helper biomarker, but is also functional and promotes strong B-cell help and ensuing immunoglobulin G production. These findings open the way to defining new diagnostic and therapeutic strategies in modulating humoral responses in alloimmunization, and possibly vaccination, autoimmunity and immune deficiencies. Copyright© Ferrata Storti Foundation.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26250578      PMCID: PMC4825309          DOI: 10.3324/haematol.2015.132738

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


  48 in total

1.  The interaction of TIGIT with PVR and PVRL2 inhibits human NK cell cytotoxicity.

Authors:  Noa Stanietsky; Hrvoje Simic; Jurica Arapovic; Amir Toporik; Ofer Levy; Amit Novik; Zurit Levine; Meirav Beiman; Liat Dassa; Hagit Achdout; Noam Stern-Ginossar; Pinhas Tsukerman; Stipan Jonjic; Ofer Mandelboim
Journal:  Proc Natl Acad Sci U S A       Date:  2009-10-07       Impact factor: 11.205

2.  Germinal center T follicular helper cell IL-4 production is dependent on signaling lymphocytic activation molecule receptor (CD150).

Authors:  Isharat Yusuf; Robin Kageyama; Laurel Monticelli; Robert J Johnston; Daniel Ditoro; Kyle Hansen; Burton Barnett; Shane Crotty
Journal:  J Immunol       Date:  2010-06-04       Impact factor: 5.422

3.  Cutting edge: TIGIT has T cell-intrinsic inhibitory functions.

Authors:  Nicole Joller; Jason P Hafler; Boel Brynedal; Nasim Kassam; Silvia Spoerl; Steven D Levin; Arlene H Sharpe; Vijay K Kuchroo
Journal:  J Immunol       Date:  2011-01-03       Impact factor: 5.422

4.  The PD-1/PD-L1 axis modulates the natural killer cell versus multiple myeloma effect: a therapeutic target for CT-011, a novel monoclonal anti-PD-1 antibody.

Authors:  Don M Benson; Courtney E Bakan; Anjali Mishra; Craig C Hofmeister; Yvonne Efebera; Brian Becknell; Robert A Baiocchi; Jianying Zhang; Jianhua Yu; Megan K Smith; Carli N Greenfield; Pierluigi Porcu; Steven M Devine; Rinat Rotem-Yehudar; Gerard Lozanski; John C Byrd; Michael A Caligiuri
Journal:  Blood       Date:  2010-05-11       Impact factor: 22.113

5.  High expression of the inhibitory receptor BTLA in T-follicular helper cells and in B-cell small lymphocytic lymphoma/chronic lymphocytic leukemia.

Authors:  Hasni M'Hidi; Marie-Laure Thibult; Bruno Chetaille; Françoise Rey; Reda Bouadallah; Richard Nicollas; Daniel Olive; Luc Xerri
Journal:  Am J Clin Pathol       Date:  2009-10       Impact factor: 2.493

6.  The surface protein TIGIT suppresses T cell activation by promoting the generation of mature immunoregulatory dendritic cells.

Authors:  Xin Yu; Kristin Harden; Lino C Gonzalez; Michelle Francesco; Eugene Chiang; Bryan Irving; Irene Tom; Sinisa Ivelja; Canio J Refino; Hilary Clark; Dan Eaton; Jane L Grogan
Journal:  Nat Immunol       Date:  2008-11-16       Impact factor: 25.606

7.  A novel molecular interaction for the adhesion of follicular CD4 T cells to follicular DC.

Authors:  Kent S Boles; William Vermi; Fabio Facchetti; Anja Fuchs; Timothy J Wilson; Thomas G Diacovo; Marina Cella; Marco Colonna
Journal:  Eur J Immunol       Date:  2009-03       Impact factor: 5.532

8.  Expansion of circulating T cells resembling follicular helper T cells is a fixed phenotype that identifies a subset of severe systemic lupus erythematosus.

Authors:  Nicholas Simpson; Paul A Gatenby; Anastasia Wilson; Shreya Malik; David A Fulcher; Stuart G Tangye; Harinder Manku; Timothy J Vyse; Giovanna Roncador; Gavin A Huttley; Christopher C Goodnow; Carola G Vinuesa; Matthew C Cook
Journal:  Arthritis Rheum       Date:  2010-01

9.  Enhancing SIV-specific immunity in vivo by PD-1 blockade.

Authors:  Vijayakumar Velu; Kehmia Titanji; Baogong Zhu; Sajid Husain; Annette Pladevega; Lilin Lai; Thomas H Vanderford; Lakshmi Chennareddi; Guido Silvestri; Gordon J Freeman; Rafi Ahmed; Rama Rao Amara
Journal:  Nature       Date:  2008-12-10       Impact factor: 49.962

10.  Cytokine-secreting follicular T cells shape the antibody repertoire.

Authors:  R Lee Reinhardt; Hong-Erh Liang; Richard M Locksley
Journal:  Nat Immunol       Date:  2009-03-01       Impact factor: 25.606

View more
  37 in total

1.  Immune Regulation of sickle Cell Alloimmunization.

Authors:  Karina Yazdanbakhsh; Beth H Shaz; Christopher D Hillyer
Journal:  ISBT Sci Ser       Date:  2016-11-15

2.  TIGIT-positive circulating follicular helper T cells and sickle cell alloimmunization.

Authors:  France Pirenne
Journal:  Haematologica       Date:  2015-11       Impact factor: 9.941

3.  Whole-blood phenotyping to assess alloimmunization status in transfused sickle cell disease patients.

Authors:  Marie Tamagne; Sadaf Pakdaman; Pablo Bartolucci; Anoosha Habibi; Frédéric Galactéros; France Pirenne; Benoît Vingert
Journal:  Blood Adv       Date:  2021-03-09

4.  Recipient priming to one RBC alloantigen directly enhances subsequent alloimmunization in mice.

Authors:  Seema R Patel; Ashley Bennett; Kathryn Girard-Pierce; Cheryl L Maier; Satheesh Chonat; Connie M Arthur; Patricia E Zerra; Amanda Mener; Sean R Stowell
Journal:  Blood Adv       Date:  2018-01-23

Review 5.  Alteration of lymphocyte phenotype and function in sickle cell anemia: Implications for vaccine responses.

Authors:  Emmanuel Balandya; Teri Reynolds; Stephen Obaro; Julie Makani
Journal:  Am J Hematol       Date:  2016-07-14       Impact factor: 10.047

6.  TIGIT signalling pathway negatively regulates CD4+ T-cell responses in systemic lupus erythematosus.

Authors:  Lie Mao; Hongyan Hou; Shiji Wu; Yu Zhou; Juan Wang; Jing Yu; Xiaohui Wu; Yanfang Lu; Liyan Mao; Munyemana Jean Bosco; Feng Wang; Ziyong Sun
Journal:  Immunology       Date:  2017-02-20       Impact factor: 7.397

7.  TIGIT and PD-1 Mark Intratumoral T Cells with Reduced Effector Function in B-cell Non-Hodgkin Lymphoma.

Authors:  Sarah E Josefsson; Klaus Beiske; Yngvild N Blaker; Mette S Førsund; Harald Holte; Bjørn Østenstad; Eva Kimby; Hakan Köksal; Sébastien Wälchli; Baoyan Bai; Erlend B Smeland; Ronald Levy; Arne Kolstad; Kanutte Huse; June H Myklebust
Journal:  Cancer Immunol Res       Date:  2019-01-18       Impact factor: 11.151

8.  T Cells Expressing Checkpoint Receptor TIGIT Are Enriched in Follicular Lymphoma Tumors and Characterized by Reversible Suppression of T-cell Receptor Signaling.

Authors:  Sarah E Josefsson; Kanutte Huse; Arne Kolstad; Klaus Beiske; Daniela Pende; Chloé B Steen; Else Marit Inderberg; Ole Christian Lingjærde; Bjørn Østenstad; Erlend B Smeland; Ronald Levy; Jonathan M Irish; June H Myklebust
Journal:  Clin Cancer Res       Date:  2017-12-07       Impact factor: 12.531

Review 9.  How I safely transfuse patients with sickle-cell disease and manage delayed hemolytic transfusion reactions.

Authors:  France Pirenne; Karina Yazdanbakhsh
Journal:  Blood       Date:  2018-05-03       Impact factor: 22.113

10.  Chronic HIV-1 Infection Impairs Superantigen-Induced Activation of Peripheral CD4+CXCR5+PD-1+ Cells, With Relative Preservation of Recall Antigen-Specific Responses.

Authors:  Katherine J Nicholas; David K Flaherty; Rita M Smith; D Noah Sather; Spyros A Kalams
Journal:  J Acquir Immune Defic Syndr       Date:  2017-01-01       Impact factor: 3.731

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.